Abstract
VARICELLA can be a life-threatening infection in immunocompromised patients. Because a large number of patients with primary or acquired immunodeficiencies are cared for at the University of Minnesota Health Sciences Center, we found it desirable to maintain a supply of zoster immune plasma for attempted prevention of varicelia in such patients. The results of ZIP prophylaxis in 31 of our immunocompromised patients were recently published? The present report expands our study to 50 patients, describes the kinetics of passively transferred varicella-zoster virus antibodies, and provides data suggesting that plasma should be transfused as soon as possible after exposure.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
